585 related articles for article (PubMed ID: 22864903)
1. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
[TBL] [Abstract][Full Text] [Related]
5. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2013 May; 45(5):387-90. PubMed ID: 23225247
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
Ishibashi Y; Nishino Y; Matsui T; Takeuchi M; Yamagishi S
Metabolism; 2011 Sep; 60(9):1271-7. PubMed ID: 21388644
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
11. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Okuda S; Imaizumi T
Ophthalmic Res; 2008; 40(1):10-5. PubMed ID: 18025836
[TBL] [Abstract][Full Text] [Related]
12. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
16. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.
Ojima A; Matsui T; Nishino Y; Nakamura N; Yamagishi S
Horm Metab Res; 2015 Aug; 47(9):686-92. PubMed ID: 25611208
[TBL] [Abstract][Full Text] [Related]
18. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation.
Ishibashi Y; Matsui T; Ohta K; Tanoue R; Takeuchi M; Asanuma K; Fukami K; Okuda S; Nakamura K; Yamagishi S
Microvasc Res; 2013 Jan; 85():54-8. PubMed ID: 23108227
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
Yamagishi S; Inagaki Y; Okamoto T; Amano S; Koga K; Takeuchi M
Kidney Int; 2003 Feb; 63(2):464-73. PubMed ID: 12631112
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
